Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). (Q39937379)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

title

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

author name string

M Arpinati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

G Chirumbolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

B Nicolini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

D Rondelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

22 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

253-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18806836 AND SRC:MED&resulttype=core&format=json

Approval summary for bortezomib for injection in the treatment of multiple myeloma

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Clinical update: proteasome inhibitors in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Antigen presentation in graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Generation of dendritic cells from positively selected CD14 monocytes for anti-tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Higher numbers of blood CD14 cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021

Human CD34( ) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021

Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021

Increased donor CD86 CD14 cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021

Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2008.312

7 January 2021